Finding 1148412 (2024-001)

Significant Deficiency Repeat Finding
Requirement
AB
Questioned Costs
-
Year
2024
Accepted
2025-07-25
Audit: 363060
Auditor: Bdo

AI Summary

  • Core Issue: PSI's internal control processes for reviewing and approving expenditures did not function as intended, leading to misrecorded expenses.
  • Impacted Requirements: Compliance with federal financial management standards under §200.302 and §200.303 was not met, risking future noncompliance.
  • Recommended Follow-Up: PSI should reinforce adherence to its expenditure policies and provide staff training to ensure timely approval and accurate recording of expenses.

Finding Text

Internal Control over Compliance and Compliance with Activities Allowed or Unallowed and Allowable Costs and Cost Principles See Schedule of Findings and Questioned Costs for chart/table. Criteria or Specific Requirement: In accordance with §200.302 Financial Management, a non-federal entity's financial management systems, including records documenting compliance with federal statutes, regulations, and the terms and conditions of the federal award, must be sufficient to permit the preparation of reports required by general and program-specific terms and conditions; and the tracing of funds to a level of expenditures adequate to establish that such funds have been used according to the federal statutes, regulations, and the terms and conditions of the federal award. The financial management system of each non-federal entity must provide for the following: (1) Identification, in its accounts, of all federal awards received and expended and the federal programs under which they were received. (2) Accurate, current, and complete disclosure of the financial results of each federal award or program in accordance with the reporting requirements set forth in §200.327 Financial Reporting and §200.328 Monitoring and Reporting Program Performance. (3) Records that identify adequately the source and application of funds for federally-funded activities. (4) Effective control over, and accountability for, all funds, property, and other assets. Additionally, §200.303 Internal Controls states that a non-federal entity must (a) establish and maintain effective internal control over the federal award that provides reasonable assurance that the non-federal entity is managing the federal award in compliance with federal statutes, regulations, and the terms and conditions of the federal award. Condition: PSI has documented expenditure policies and procedures. However, as identified below, the review and approval process did not operate as designed. PSI’s policies are designed to ensure expenses are reviewed and approved timely to ensure proper recording in the books and records. The following errors were identified during our testing of payroll and non-payroll expenditures: BDO tested 120 payroll and non-payroll expenditures. BDO also separately tested 40 transactions from the indirect cost pool. Based on that testing, BDO identified instances in which the expenditures were reported within the incorrect period on an accrual basis. These expenditures were valid expenditures within the overall award period. o BDO identified one of the 80 payroll and non-payroll transactions tested totaling $860 was improperly recorded on the Schedule as it related to a prior period (calendar year 2023). o For indirect cost pool testing, one of the 40 transactions tested totaling $180 was recorded in error as it related to a prior period (2023). Questioned Costs: As all of the costs noted were within the award period of performance, there are no questioned costs to report. Context: This is a condition identified per review of PSI’s compliance with allocability and allowability provisions of the Uniform Guidance. The prevalence of these findings is detailed in the condition section above. Samples were selected using a non-statistical method. Cause: PSI has documented expenditure policies and procedures regarding the timely processing and approval of expenditures incurred. However, as identified above, the review and approval process for the samples identified above did not operate as designed. Effect: The lack of adherence to established internal control policies and procedures can lead to noncompliance with federal statutes, regulations, and the provisions of award agreements which could ultimately lead to disallowed costs for the major programs. Repeat Finding: This is a repeat finding from the previous year. This was reported as finding 2023-001 in the 2023 schedule of findings and questioned costs. Recommendation: BDO recommends PSI adhere to its documented policies and procedures regarding authorization and timely approval and recording of expenditures. Views of Responsible Officials: PSI management agrees with the finding and recommendations set forth within and will provide additional training to staff members to ensure compliance with established policies and procedures. Refer to management’s corrective action plan for additional information.

Categories

Allowable Costs / Cost Principles Subrecipient Monitoring Period of Performance Reporting Matching / Level of Effort / Earmarking

Other Findings in this Audit

  • 571964 2024-003
    Significant Deficiency Repeat
  • 571965 2024-004
    Significant Deficiency Repeat
  • 571966 2024-005
    Significant Deficiency Repeat
  • 571967 2024-004
    Significant Deficiency Repeat
  • 571968 2024-003
    Significant Deficiency Repeat
  • 571969 2024-002
    Significant Deficiency
  • 571970 2024-001
    Significant Deficiency Repeat
  • 571971 2024-004
    Significant Deficiency Repeat
  • 571972 2024-004
    Significant Deficiency Repeat
  • 571973 2024-004
    Significant Deficiency Repeat
  • 571974 2024-005
    Significant Deficiency Repeat
  • 571975 2024-004
    Significant Deficiency Repeat
  • 571976 2024-002
    Significant Deficiency
  • 571977 2024-004
    Significant Deficiency Repeat
  • 1148406 2024-003
    Significant Deficiency Repeat
  • 1148407 2024-004
    Significant Deficiency Repeat
  • 1148408 2024-005
    Significant Deficiency Repeat
  • 1148409 2024-004
    Significant Deficiency Repeat
  • 1148410 2024-003
    Significant Deficiency Repeat
  • 1148411 2024-002
    Significant Deficiency
  • 1148413 2024-004
    Significant Deficiency Repeat
  • 1148414 2024-004
    Significant Deficiency Repeat
  • 1148415 2024-004
    Significant Deficiency Repeat
  • 1148416 2024-005
    Significant Deficiency Repeat
  • 1148417 2024-004
    Significant Deficiency Repeat
  • 1148418 2024-002
    Significant Deficiency
  • 1148419 2024-004
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
98.001 Usaid Foreign Assistance for Programs Overseas $15.54M
98.U00 Usaid Cost Reimbursable Contracts and Other Awards $699,472
98.001 Covid 19 - Usaid Foreign Assistance for Programs Overseas $344,479
98.U00 Covid 19 - Usaid Cost Reimbursable Contracts and Other Awards $186,371
12.420 Military Medical Research and Development $73,012
12.350 Department of Defense Hiv/aids Prevention Program $35,605
93.067 Global Aids $-1,305